Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simethicone for Post-operative Gas and Bloating in Foregut Surgery
NCT06812832Phase 4Recruiting
- Sponsor
- Madigan Army Medical Center
- Start
- Apr 2025
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in abdominal bloating, postoperative pain and flatulence comparing Simethicone Arm with Placebo Arm (2 arms). Primary endpoints: Post-operative Pain at 2 weeks, Post-operative Opioid Consumption at 2 weeks and 1 more. Started Apr 2025; status: recruiting.
02
Drugs
simethicone
03
Conditions
abdominal bloatingpostoperative painflatulence
Beyond the preview
Go deeper on NCT06812832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06812832.